Plasmablastic Lymphoma in HIV-Positive Patients

Definition

Lymphoma with plasmablastic features and negative for CD20 in an HIV-positive patient. Some patients have bone marrow involvement and a paraprotein, suggesting an overlap with plasma cell myeloma.

Epidemiology

Most patients are male.

Clinical features

Patients are immunocompromised with reduced CD4 counts and most have a history of opportunistic infections or Kaposi's sarcoma. They may have a monoclonal serum gammopathy or a mixed polyclonal cryoglobulinemia. Patients present with extramedullary tumours, most often in the oral cavity but a range of other sites have been recorded.

Histopathology

Plasmablastic cells have basophilic cytoplasm and an eccentric round nucleus with clumped chromatin and a single prominent nucleolus. There is a continuum in the cytological appearance from plasmablastic to mature plasma cells. Multinucleate plasmablasts are common. Frequent mitoses and apoptotic cells are present.

Immunohistochemistry

 

cIgH

5/111

 

cIgL

3 kappa & 2 lambda / 131

CD20

2/11

CD45

11/11

CD138

10/101

Pax-5

0/81

bcl-6

0/101

ALK-1

0/101

EBV-EBER (in situ hybridisation)

11/111

EBV-LMP (in situ hybridisation)

0/51

EBNA-2

negative1

HHV8 (IHC)

0/1

   
   

Differential diagnosis

Prognosis

This is an aggressive lymphoma with a median survival of six months.

References

1 Dong HY, Scadden DT, de Leval L, et al. Plasmablastic lymphoma in HIV-positive patients: an aggressive Epstein-Barr virus-associated extramedullary plasmacytic neoplasm. Am J Surg Pathol 2005; 29:1633-41

This page last revised 30.7.2006.

©SMUHT/PW Bishop